iPhone Will Change Health-IT, Says Datamonitor


By Neil Versel

March 18, 2008 | Following recent news that drug-reference database vendor Epocrates will be one of the first companies to develop third-party software for the iPhone, a new report suggests the too-cool-for-words Apple product could be the killer app that finally brings physicians into the digital age en masse.

“Apple’s recent announcement that it is allowing third party developers to create applications on the iPhone will have tremendous effects on the health care industry,” says a report from IT market analysis firm Datamonitor (London). “Datamonitor believes that health care technology applications — particularly electronic health records (EHRs) and clinical decision support (CDS) — will be more likely to be adopted by physicians, translating into better health care for patients.”

On Friday, ahead of the Monday release of the report, New York-based Datamonitor analyst Christine Chang put out an independent commentary on the report itself, suggesting that mobile devices could “alleviate” the perceived notion that EHR adoption has been slow in part because computers in the exam room get in the way of the traditional physician-patient relationship.

“The iPhone, however, stands out from the rest of the currently available devices because of its functionality, ease of use and, quite frankly, appearance,” Chang wrote. “The iPhone’s functionality is undisputed — as a phone, camera, media device, and Web browser all in one device — who needs anything else? Health care providers don’t want to carry around a beeper, hospital-issued phone, cell phone, BlackBerry, and tablet PC with them as they run through the corridors of a hospital. They want to carry around one device that can do everything and that’s what the iPhone is.”

Added Chang: “With no little buttons to push, the iPhone’s touch screen brings easy-to-use technology to even the most technophobic provider. Zoom-in capabilities … and the ability to flick through screens are other features that will make it easier, rather than more difficult, for providers to enter in and sort through patient information.”

Chang also noted that the iPhone can connect to the Internet and organizational networks either by Wi-Fi or cellular broadband technology.

She cited the Epocrates decision to produce an iPhone version of its software as an example of how much physician demand there is for clinical applications that work on the Apple device. (See “Epocrates Coming to an iPhone Near You.”)

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.